Patents for C12P 21 - Preparation of peptides or proteins (112,499)
04/1998
04/01/1998EP0831899A1 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (rhdv)] compositions and uses
04/01/1998EP0831895A1 Tumor associated epitopes
04/01/1998EP0831880A1 Antibody and antibody fragments for inhibiting the growth of tumors
04/01/1998EP0831866A1 Pineal gland specific gene-1
04/01/1998EP0831714A1 Monospecific antibodies and methods using them
04/01/1998EP0733208B1 Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
04/01/1998EP0668930A4 A method of identifying ligands and antagonists of ligands.
04/01/1998EP0637318B1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin
04/01/1998CN1177982A System for the expression of heterologous antigens as fusion proteins
04/01/1998CN1177909A Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
04/01/1998CN1177640A Improved heat-stable DNA polymerase
03/1998
03/31/1998US5734038 Purified polynucleotide sequence which codes for a diazepam binding inhibitor protein(or polypeptide) or an acyl-coenzyme a binding protein(or polypeptide)
03/31/1998US5734037 DNA encoding the human cytokine, interleukin-9
03/31/1998US5734035 Nematode vaccine
03/31/1998US5734026 Process for manufacturing crystals of growth hormone and crystals thereby obtained
03/31/1998US5734019 Hepatitis C virus antigen polypeptide, production method therefor, and antibody detection method
03/31/1998US5734016 Genetic engineering
03/31/1998US5734014 Polypeptide
03/31/1998US5734013 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same
03/31/1998US5733876 Method of inhibiting angiogenesis
03/31/1998US5733875 Epilepsy
03/31/1998US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
03/31/1998US5733782 Methods and compositions for high protein production from non-native DNA
03/31/1998US5733778 Vaccines, medical diagnosis
03/31/1998US5733771 cDNAs encoding minor ampullate spider silk proteins
03/31/1998US5733768 Amyloid precursor protein protease
03/31/1998US5733757 Aldol condensations for antibodies
03/31/1998US5733745 Pure genetic engineered protein
03/31/1998US5733744 Binary BAC vector
03/31/1998US5733742 Polyclonal immunoglobulin fab fragments
03/31/1998US5733726 Cytotoxicity-based genetic selection system (TOXSEL)
03/31/1998US5733720 Dna-transfected cell line susceptible to infection by herpes virus which is stably transformed with chimeric gene comprising herpes virus inducible promoter and gene coding for an enzyme, the expression of which is dependent on virus
03/31/1998US5733548 Stimulating t-cell response
03/31/1998US5733540 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
03/31/1998CA1339792C Purification of hepatitis proteins
03/31/1998CA1339791C Human nerve growth factor
03/26/1998WO1998012563A1 Method to detect dirofilaria immitis infection
03/26/1998WO1998012344A1 Human tumor necrosis factor receptor-like genes
03/26/1998WO1998012334A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/26/1998WO1998012331A1 Novel polypeptide originating in hemophilus paragallinarum and process for producing the same
03/26/1998WO1998012329A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998WO1998012326A1 Hedgehog interacting proteins and uses related thereto
03/26/1998WO1998012325A1 Human gtp binding protein gamma-3
03/26/1998WO1998012323A1 Nucleic acid encoding congenital heart disease protein and products related thereto
03/26/1998WO1998012322A1 Bone morphogenetic protein-16 (bmp-16) compositions
03/26/1998WO1998012315A1 Cell-free translational extract from eukaryotic cells that have grown in monolayers
03/26/1998WO1998012306A1 Hematopoietic stem cells and methods for generating such cells
03/26/1998WO1998012300A1 Novel host cells and methods of producing proteins
03/26/1998WO1998012224A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
03/26/1998WO1998012220A2 Novel tumor proteins
03/26/1998WO1998012207A1 High level expression of proteins
03/26/1998WO1998012204A1 Human b-cell translocation genes-2 and 3
03/26/1998WO1998011918A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation
03/26/1998WO1997049832A3 Method of identifying cytochrome p450
03/26/1998WO1997048724A3 Human metabotropic glutamate receptor
03/26/1998WO1997048370A3 Vaccines comprising synthetic genes
03/26/1998WO1997040063A3 Pathogenic escherichia coli associated protein espa
03/26/1998CA2267288A1 Hematopoietic stem cells and methods for generating such cells
03/26/1998CA2266684A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation
03/26/1998CA2266585A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
03/26/1998CA2266428A1 Method to detect dirofilaria immitis infection
03/26/1998CA2266425A1 Human b-cell translocation genes-2 and 3
03/26/1998CA2266341A1 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998CA2266339A1 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/26/1998CA2264542A1 Human gtp binding protein gamma-3
03/26/1998CA2263818A1 Novel tumor proteins
03/26/1998CA2236165A1 Novel polypeptide from haemophilus paragallinarum and process for preparing the same
03/25/1998EP0830456A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
03/25/1998EP0830450A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
03/25/1998EP0830376A1 Process for producing erythropoietin containing no animal proteins
03/25/1998EP0830373A1 Cd6 ligand
03/25/1998EP0830370A1 N-1-carboxyalkyl derivatives of lsd
03/25/1998EP0830143A1 Use of leukemia inhibitory factor and endothelin antagonists
03/25/1998EP0830139A1 Modified myelin protein molecules
03/25/1998EP0830138A1 Use of fibroblast growth factors to stimulate bone growth
03/25/1998EP0830130A1 Tnf-alpha converting enzyme
03/25/1998EP0679094B1 Compounds for targeting
03/25/1998EP0584166B1 Yeast promoter and use thereof
03/25/1998EP0461165B2 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site
03/25/1998CN1177380A DNA integration by transposition
03/25/1998CN1177351A Hydroxylamine derivatives useful for enhancing molecular chaperon prodn. and the prepn. thereof
03/25/1998CN1177302A Lymphotoxin-
03/25/1998CN1037857C Method for preparing peptide derivatives by using black chain mould
03/25/1998CN1037844C Tnf-muteins
03/24/1998US5731428 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
03/24/1998US5731427 Nucleic acids encoding a gap-associated protein
03/24/1998US5731284 Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
03/24/1998US5731200 Isolated nucleic acid encoding receptor-like TGF-β1 binding protein
03/24/1998US5731195 Specified amino acid sequences
03/24/1998US5731190 Penton base protein and methods of using same
03/24/1998US5731183 Bacillus-derived transglutaminase
03/24/1998US5731170 DNA encoding a growth factor specific for epithelial cells
03/24/1998US5731168 Method for making heteromultimeric polypeptides
03/24/1998US5731166 Recombinant production of chemotactic CP-10 polypeptides and therapeutic methods using them
03/24/1998US5731154 Method for detecting human contactin
03/24/1998US5731151 Tuberculosis vaccine
03/24/1998US5731149 Antibiotic cryptdin peptides and methods of their use
03/24/1998US5730982 Therapeutic use of hypervariable region of monoclonal antibody M195 and constructs thereof
03/24/1998US5730981 Monoclonal anti-ganglioside antibody and its preparation
03/24/1998US5730980 Methods and compositions for ameliorating the symptoms of sepsis